Literature DB >> 24866598

Incidence of infectious complications after extracorporeal shock wave lithotripsy in patients without associated risk factors.

Alejandra Mira Moreno1, María Dolores Montoya Lirola2, Pedro José García Tabar2, Juan Francisco Galiano Baena2, José Antonio Tenza Tenza2, Juan José Lobato Encinas2.   

Abstract

PURPOSE: We determined the incidence of infectious complications (asymptomatic bacteriuria, urinary tract infection and urosepsis) in patients without associated risk factors treated with extracorporeal shock wave lithotripsy.
MATERIALS AND METHODS: We performed an observational, prospective cohort study between October 2010 and June 2013. We included all patients without risk factors who were treated with extracorporeal shock wave lithotripsy for kidney or ureteral lithiasis. All patients underwent urine culture 5 days before the procedure. Another urine culture was performed 7 days after lithotripsy. No patient received antibiotics.
RESULTS: Initially 366 patients with a mean ± SD age of 53 ± 13 years were enrolled in the study. A total of 64 patients (17.5%) underwent extracorporeal shock wave lithotripsy with a previously placed Double-J® stent. After lithotripsy urine culture was positive in 20 patients (5.8%), of whom 4 (1.2%) presented with symptomatic urinary infection and the remaining 4.6% showed no symptoms. Urosepsis did not develop in any case. In our study patient age was an independent risk factor for bacteriuria after lithotripsy.
CONCLUSIONS: The incidence of infectious complications after extracorporeal shock wave lithotripsy in patients without risk factors is low. This leads us to conclude that without defined risk factors antibiotic prophylaxis is not justified. Also, elderly patients were more at risk for bacteriuria after extracorporeal shock wave lithotripsy and, thus, for a possible infectious complication.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibiotic prophylaxis; kidney; lithotripsy; ureter; urolithiasis

Mesh:

Year:  2014        PMID: 24866598     DOI: 10.1016/j.juro.2014.05.091

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Antibiotic prophylaxis in the prevention of urinary tract infection in patients with sterile urine before extracorporeal shock wave lithotripsy.

Authors:  Hamdi Shafi; Masomeh Ilkhani; Zeinab Darabi Ahangar; Masomeh Bayani
Journal:  Caspian J Intern Med       Date:  2018

2.  Percutaneous nephrolithotomy in octogenarians and beyond: How old is too old?

Authors:  Bradley Morganstern; Riccardo Galli; Piruz Motamedinia; David Leavitt; Mohamed Keheila; Eric Ghiraldi; David Hoenig; Arthur Smith; Zeph Okeke
Journal:  Asian J Urol       Date:  2015-09-04

Review 3.  Ureteroscopy and stone treatment in the elderly (≥70 years): prospective outcomes over 5- years with a review of literature.

Authors:  Sarah Prattley; James Voss; Stephanie Cheung; Robert Geraghty; Patrick Jones; Bhaskar K Somani
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

4.  Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi.

Authors:  Christian D Fankhauser; Thomas Hermanns; Laura Lieger; Olivia Diethelm; Martin Umbehr; Thomas Luginbühl; Tullio Sulser; Michael Müntener; Cédric Poyet
Journal:  Clin Kidney J       Date:  2018-01-25

Review 5.  Indications and contraindications for shock wave lithotripsy and how to improve outcomes.

Authors:  Luke F Reynolds; Tad Kroczak; Kenneth T Pace
Journal:  Asian J Urol       Date:  2018-09-04

6.  Effectiveness of Flexible Ureterorenoscopy Versus Extracorporeal Shock Wave Lithotripsy for Renal Calculi of 5-15 mm: Results of a Randomized Controlled Trial.

Authors:  Christian Daniel Fankhauser; Damian Weber; Michael Müntener; Cedric Poyet; Tullio Sulser; Thomas Hermanns
Journal:  Eur Urol Open Sci       Date:  2021-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.